Andrea Ciolfi

Has grant

Senior Staff Scientist

Ospedale Pediatrico Bambino Gesù
Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Definizione di una procedura analitica standardizzata per la reinterpretazione periodica di varianti genomiche nella pratica clinica

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Utilizzo di reti neurali per l’identificazione di nuove signature di metilazione di DNA da sangue in pazienti affetti da malattie mendeliane del neurosviluppo.

Open Date: 2022-01-01

Close Date: 2022-12-01

Grant: Close

Sviluppo di nuove tecniche di classificazione automatica di dati epigenomici per pazienti senza diagnosi

Open Date: 2021-01-01

Close Date: 2021-12-01

Articles (13)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Tubulinopathies encompass a wide spectrum of disorders resulting from variants in genes encoding α- and β-tubulins, the key components of microtubules. While previous studies have linked de novo or dominantly inherited TUBA4A missense variants to neurodegenerative phenotypes, including amyotrophic lateral sclerosis, frontotemporal dementia, hereditary spastic ataxia, and more recently, an isolated report of congenital myopathy, the full phenotypic and genotypic spectrum of TUBA4A -related disorders remains incompletely characterised. In this multi-centre study, we identified 13 novel TUBA4A missense variants in 31 individuals from 19 unrelated families. Remarkably, affected individuals in 17 families presented with a primary axial myopathy without any identified CNS involvement or history of such disease. In the remaining two families, we observed probands with cerebellar ataxia and epilepsy accompanying proximal and axial muscle weakness, establishing the first documented association between TUBA4A variants and multisystem proteinopathy. Our cohort exhibited diverse genotypes and associated inheritance patterns: four families demonstrated autosomal dominant transmission through heterozygous variants in TUBA4A , three probands had homozygous TUBA4A variants, where the biallelic genotype was found to be associated with the disease, and the heterozygous carriers were asymptomatic; five probands carried de novo variants, and nine probands with heterozygous TUBA4A variants were classified as "isolated-sporadic cases" where parental samples were unavailable. Clinical phenotypes ranged from mild to severe myopathy, predominantly affecting the axial and paraspinal muscles. We observed a range of disease onset, from congenital to late adulthood. Creatine kinase levels were also variable, ranging from normal to highly elevated. Cardiac function remained preserved across the cohort. Muscle biopsies revealed a range of pathologies, including myofibre size variation, myofibre atrophy, nemaline bodies, core-like regions, internal nuclei, and endomysial fibrosis. Immunohistochemical staining showed evidence of proteinopathy, with autophagic features and TUBA4A accumulation in patient myofibres. Complementary in silico and in vitro investigations suggested that the identified TUBA4A substitutions cause significant protein abnormalities and may differentially impact microtubule dynamics. Our findings establish myo-tubulinopathies as distinct clinical entities, encompassing both primary myopathies and multisystem proteinopathies with muscle involvement. This study broadens the phenotypic and genotypic spectrum of TUBA4A -related disorders beyond autosomal dominant or de novo mechanisms and neurodegenerative presentations. These results underscore the importance of considering TUBA4A variants in the differential diagnosis of axial myopathies and multisystem proteinopathies, regardless of central nervous system (CNS) involvement.

Year:

2025

Year:

2024

Year:

2024

Key Points Ketogenic diet can change the metabolism in the body and helped restore the function of altered pathways in nephropathic cystinosis. Ketogenic diet had significant benefits for preventing kidney damage, even when initiated after the onset of kidney impairment. Ketogenic diet may provide a partial therapeutic alternative in countries where cysteamine therapy is too expensive. Background Nephropathic cystinosis is a rare inherited lysosomal storage disorder caused by mutations in the CTNS gene that encodes for cystinosin, a lysosomal cystine/H + symporter. From the standpoint of the kidneys, patients develop early-onset renal Fanconi syndrome and progressive CKD. Current therapy with cysteamine delays but does not prevent kidney failure and has significant side effects that limit adherence and reduce the quality of life of patients. Methods We have tested biochemically and histologically the effects of ketogenic diet on kidney disease of two animal models of nephropathic cystinosis. Results When Ctns −/− mice were fed with ketogenic diet from 3 to 12 months of age, we observed significant nearly complete prevention of Fanconi syndrome, including low molecular weight proteinuria, glycosuria, and polyuria. Compared with wild-type animals, BUN at 12 months was higher in cystinotic mice fed with standard diet ( P < 0.001), but not with ketogenic diet. At sacrifice, kidneys of knockout mice fed with ketogenic diet appeared macroscopically similar to those of wild-type animals, which was reflected microscopically by a significant reduction of interstitial cell infiltration (CD3 and CD68 positive cells, P < 0.01), of interstitial fibrosis (Masson and α -smooth muscle actin staining, P < 0.001), and of apoptosis (cleaved caspase-3 levels; P < 0.001), and by indirect evidence of restoration of a normal autophagic flux (SQSTM1/p62 and LC3-II expression, P < 0.05). Beneficial effects of ketogenic diet on tubular function were also observed after mice were fed with this ketogenic diet from the age of 6 months to the age of 15 months, after they had developed proximal tubular dysfunction. Although slightly less pronounced, these results were replicated in Ctns −/− rats fed with ketogenic diet from 2 to 8 months of life. Conclusions These results indicate significant mitigation of the kidney phenotype in cystinotic animals fed with ketogenic diet.

Year:

2024

Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (49)

Peter Kang

Executive, Administrative, and Managerial Staff, Associate Dean

University of Minnesota

UNITED STATES
View details

Stefan Barakat

Associate professor

Erasmus MC

NETHERLANDS
View details

Tim Schedl

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Pamela Trapane

Professor and Chief, Division of Pediatric Genetics

University of Florida College of Medicine - Jacksonville

UNITED STATES
View details

Anna Jansen

University of Antwerp

BELGIUM
View details

Carol Saunders

Children's Mercy Hospital

UNITED STATES
View details

Paulino Gomez-Puertas

Consejo Superior de Investigaciones Cientificas

SPAIN
View details

Olaf Riess

University of Tuebingen

GERMANY
View details

Andreas Roos

-

GERMANY
View details

Ohad S. Birk

-

ISRAEL
View details

Matthias Begemann

Medizinische Fakultät der RWTH Aachen

GERMANY
View details

Marco Savarese

University of Helsinki

FINLAND
View details

Sigmar Stricker

Professor

Karl Landsteiner University of Health Sciences

AUSTRIA
View details

Marco Tartaglia

Head

Ospedale Pediatrico Bambino Gesù

ITALY
View details

Joachim Weis

Medizinische Fakultät der RWTH Aachen

GERMANY
View details

Martin Wiesmann

University Hospital RWTH Aachen

GERMANY
View details

B. Callewaert

Associate Professor

Ghent University

BELGIUM
View details

Zeynep Tumer

Clinical Professor

University of Copenhagen

DENMARK
View details

Stephen Pak

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Chiara Folland

University of Western Australia

AUSTRALIA
View details

Weimin Yuan

Staff scientist

Washington University in St. Louis

UNITED STATES
View details

Giorgio Tasca

Clinical Prof of Neuromuscular Science

Newcastle University

UNITED KINGDOM
View details

Sven Geißler

Professor of the Biology of Musculoskeletal Regeneration

Charité - Universitätsmedizin Berlin

GERMANY
View details

Judith Frydman

Professor

Stanford University

UNITED STATES
View details

Evelina Miele

Associate Medical Director

Ospedale Pediatrico Bambino Gesù

ITALY
View details

Marije Meuwissen

-

BELGIUM
View details

Micheil Innes

Associate Professor

University of Calgary

CANADA
View details

Gary A Silverman

Chair

Washington University in Saint Louis School of Medicine

UNITED STATES
View details

Mridul Johari

University of Western Australia

AUSTRALIA
View details

Renske Oegema

UMC Utrecht

NETHERLANDS
View details

Martin Häusler

Head of Division, Prof. Dr. med

RWTH Aachen University

GERMANY
View details

Manfred Gossen

-

GERMANY
View details

Gael Nicolas

PUPH

University of Rouen

FRANCE
View details

David J. Amor

University of Melbourne

AUSTRALIA
View details

Ichizo Nishino

Director

-

JAPAN
View details

Wim Van Paesschen

Professor in Neurology

-

BELGIUM
View details

Andrea Maier

-

GERMANY
View details

Hanns Lochmüller

Senior Scientist

-

CANADA
View details

Alan Beggs

Sir Edwin & Lady Manton Professor

Harvard Medical School

UNITED STATES
View details

Stefan Wolking

-

GERMANY
View details

Yoshihiko Saito

National Center of Neurology and Psychiatry

JAPAN
View details

Marcello Niceta

Principal Investigator

Ospedale Pediatrico Bambino Gesù

ITALY
View details

Ingo Kurth

Head of Institute

RWTH Aachen University

GERMANY
View details

Ana Töpf

Senior Research Scientist

Newcastle University

UNITED KINGDOM
View details

John Vissing

-

DENMARK
View details

Chiara Leoni

MD, PhD

Agostino Gemelli University Polyclinic

ITALY
View details

Thomas Smol

PU-PH

Université de Lille

FRANCE
View details

Gianina Ravenscroft

University of Western Australia

AUSTRALIA
View details

Yvonne Weber

Leader of the Dpt. of Epileptology/ Prof

RWTH Aachen University

GERMANY
View details